{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T20:52:27Z","timestamp":1781556747235,"version":"3.54.5"},"reference-count":18,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,3]]},"abstract":"<jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>Early initiation of antiretroviral therapy (ART) can reduce HIV-related morbidity and mortality. We described treatment outcomes of children living with HIV identified through the early infant diagnosis (EID) program and linked to the Thai National AIDS Program (NAP).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>We used the Thai NAP database to conduct a cohort analysis of infants identified through the EID program who initiated ART from August 2014 to July 2018, with data cutoff on 31 December 2023. The Thai NAP is a national database linked to public hospitals in Thailand and a vital status registry. First-line ART was a lopinavir\/ritonavir-based regimen; pediatric dolutegravir became available in May 2023. Attrition outcomes included death and loss-to-follow-up (LTFU). Virologic suppression was defined as plasma HIV RNA &lt;200 copies\/mL. The overall 7-year survival rate was estimated using the Kaplan\u2013Meier estimate.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>The median [interquartile range (IQR)] age at ART initiation was 3.3 (2.2\u20136) months for the 230 infants included. Twenty children [8.7%, 95% confidence interval (CI): 5.4\u201313.1] died at a median (IQR) age of 1.1 (0.6\u20133.0) years. LTFU was 44 (19.1%, 95% CI: 14.3\u201324.8) at the median (IQR) age of 3.6 (2.0\u20135.6) years. Overall, the 7-year survival rate was 90.7% (95% CI: 85.6\u201394.1). Among 166 children retained on ART, the median (IQR) age at the last visit was 7.7 (6.7\u20138.7) years. Of these, 107 (64.5%) children transitioned to dolutegravir-based regimens. Overall, virologic suppression was achieved in 144 children at the last visit, representing 62.6% of children who initiated ART and 86.7% of children who remained in care.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions:<\/jats:title>\n                    <jats:p>Children diagnosed with HIV through EID and linked to the Thai NAP had promising 7-year survival rates but substantial LTFU. Strategies to improve retention and re-engagement in care and are essential for better outcomes.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/inf.0000000000005041","type":"journal-article","created":{"date-parts":[[2026,2,12]],"date-time":"2026-02-12T05:04:42Z","timestamp":1770872682000},"page":"251-257","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["High Viral Suppression Rates and Attrition Rates Among Children With Perinatally Acquired HIV in the Thai National AIDS Program, 2023"],"prefix":"10.1097","volume":"45","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8995-0990","authenticated-orcid":false,"given":"Rapisa","family":"Nantanee","sequence":"first","affiliation":[{"name":"Department of Pediatrics, Faculty of Medicine, Chulalongkorn University, Bangkok"},{"name":"Center of Excellence in Pediatric Infectious Diseases and Vaccines, Chulalongkorn University, Bangkok"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rangsima","family":"Lolekha","sequence":"additional","affiliation":[{"name":"Division of Global HIV and TB, U.S. Centers for Disease Control and Prevention, Nonthaburi"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheewanan","family":"Lertpiriyasuwat","sequence":"additional","affiliation":[{"name":"Division of AIDS and STIs, Department of Disease Control"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wiroj","family":"Puangtaptim","sequence":"additional","affiliation":[{"name":"Department of Medical Sciences, Ministry of Public Health, Nonthaburi"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thidarat","family":"Jupimai","sequence":"additional","affiliation":[{"name":"Center of Excellence in Pediatric Infectious Diseases and Vaccines, Chulalongkorn University, Bangkok"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juthamanee","family":"Moonwong","sequence":"additional","affiliation":[{"name":"Center of Excellence in Pediatric Infectious Diseases and Vaccines, Chulalongkorn University, Bangkok"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiratchaya","family":"Sophonphan","sequence":"additional","affiliation":[{"name":"Center of Excellence in Pediatric Infectious Diseases and Vaccines, Chulalongkorn University, Bangkok"},{"name":"The HIV Netherlands Australia Thailand Research Collaboration, Thai Red Cross AIDS Research Center, Bangkok, Thailand."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thanyawee","family":"Puthanakit","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Faculty of Medicine, Chulalongkorn University, Bangkok"},{"name":"Center of Excellence in Pediatric Infectious Diseases and Vaccines, Chulalongkorn University, Bangkok"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"on behalf of the ACC Working Group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2025,11,20]]},"reference":[{"key":"R4-20260615","doi-asserted-by":"crossref","first-page":"2787","DOI":"10.1097\/QAD.0000000000000027","article-title":"The magnitude of loss to follow-up of HIV-exposed infants along the prevention of mother-to-child HIV transmission continuum of care: a systematic review and meta-analysis.","volume":"27","author":"Sibanda","year":"2013","journal-title":"AIDS"},{"key":"R5-20260615","doi-asserted-by":"crossref","first-page":"192","DOI":"10.21106\/ijma.268","article-title":"Integration of neonatal and child health interventions with pediatric HIV interventions in global health.","volume":"7","author":"Smith","year":"2018","journal-title":"Int J MCH AIDS"},{"key":"R6-20260615","doi-asserted-by":"crossref","first-page":"562","DOI":"10.15585\/mmwr.mm6522a2","article-title":"Elimination of mother-to-child transmission of HIV - Thailand.","volume":"65","author":"Lolekha","year":"2016","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"R7-20260615","doi-asserted-by":"crossref","first-page":"e25450","DOI":"10.1002\/jia2.25450","article-title":"Implementation of an active case management network to identify HIV-positive infants and accelerate the initiation of antiretroviral therapy, Thailand 2015 to 2018.","volume":"23","author":"Lolekha","year":"2020","journal-title":"J Int AIDS Soc"},{"key":"R9-20260615","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1097\/QAI.0b013e31829f05ac","article-title":"Viral load monitoring as a tool to reinforce adherence: a systematic review.","volume":"64","author":"Bonner","year":"2013","journal-title":"J Acquir Immune Defic Syndr"},{"key":"R11-20260615","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.childyouth.2014.03.024","article-title":"The Social Determinants of Health as they relate to children and youth growing up with HIV infection in sub-Saharan Africa.","volume":"45","author":"Skovdal","year":"2014","journal-title":"Child Youth Serv Rev"},{"key":"R12-20260615","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.jpeds.2017.05.035","article-title":"Attrition and mortality of children receiving antiretroviral treatment through the Universal Coverage Health Program in Thailand.","volume":"188","author":"Teeraananchai","year":"2017","journal-title":"J Pediatr"},{"key":"R13-20260615","doi-asserted-by":"crossref","first-page":"2531","DOI":"10.1056\/NEJMoa2108793","article-title":"Dolutegravir as first- or second-line treatment for HIV-1 infection in children.","volume":"385","author":"Turkova","year":"2021","journal-title":"N Engl J Med"},{"issue":"RR-03","key":"R16-20260615","first-page":"1","article-title":"Revised surveillance case definition for HIV infection--United States, 2014.","volume":"63","year":"2014","journal-title":"MMWR Recomm Rep"},{"key":"R17-20260615","doi-asserted-by":"crossref","first-page":"e706","DOI":"10.1016\/S2352-3018(18)30251-0","article-title":"12-month outcomes of HIV-infected infants identified at birth at one maternity site in Johannesburg, South Africa: an observational cohort study.","volume":"5","author":"Technau","year":"2018","journal-title":"Lancet HIV"},{"key":"R18-20260615","doi-asserted-by":"crossref","first-page":"102648","DOI":"10.1016\/j.eclinm.2024.102648","article-title":"High mortality following early initiation of antiretroviral therapy in infants living with HIV from three African countries.","volume":"73","author":"Tagarro","year":"2024","journal-title":"EClinicalMedicine"},{"key":"R20-20260615","doi-asserted-by":"crossref","first-page":"2233","DOI":"10.1056\/NEJMoa0800971","article-title":"Early antiretroviral therapy and mortality among HIV-infected infants.","volume":"359","author":"Violari","year":"2008","journal-title":"N Engl J Med"},{"key":"R21-20260615","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1097\/INF.0000000000003839","article-title":"Retention and predictors of attrition among HIV-infected children on antiretroviral therapy in Cote d\u2019Ivoire between 2012 and 2016.","volume":"42","author":"Toure","year":"2023","journal-title":"Pediatr Infect Dis J"},{"key":"R22-20260615","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1186\/s12879-021-06099-3","article-title":"A 17 year experience of attrition from care among HIV infected children in Nnewi South-East Nigeria.","volume":"21","author":"Onubogu","year":"2021","journal-title":"BMC Infect Dis"},{"key":"R23-20260615","doi-asserted-by":"crossref","first-page":"2375","DOI":"10.1097\/QAD.0000000000002366","article-title":"Attrition of HIV-positive children from HIV services in low and middle-income countries.","volume":"33","author":"Carlucci","year":"2019","journal-title":"AIDS"},{"issue":"Suppl 2","key":"R24-20260615","doi-asserted-by":"crossref","first-page":"S207","DOI":"10.1097\/QAD.0000000000000095","article-title":"Linkage, initiation and retention of children in the antiretroviral therapy cascade: an overview.","volume":"27","author":"Phelps","year":"2013","journal-title":"AIDS"},{"key":"R25-20260615","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1097\/INF.0000000000003878","article-title":"Realizing the promise of dolutegravir in effectively treating children and adolescents living with HIV in real-world settings in 6 countries in Eastern and Southern Africa.","volume":"42","author":"Bacha","year":"2023","journal-title":"Pediatr Infect Dis J"},{"key":"R26-20260615","doi-asserted-by":"crossref","first-page":"2148","DOI":"10.1007\/s10461-024-04312-3","article-title":"Early effects of scaling up dolutegravir-based ARV regimens among children living with HIV in Malawi.","volume":"28","author":"Makonokaya","year":"2024","journal-title":"AIDS Behav"}],"container-title":["Pediatric Infectious Disease Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/INF.0000000000005041","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T20:00:39Z","timestamp":1781553639000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/INF.0000000000005041"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,20]]},"references-count":18,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1097\/inf.0000000000005041","relation":{},"ISSN":["0891-3668","1532-0987"],"issn-type":[{"value":"0891-3668","type":"print"},{"value":"1532-0987","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,20]]}}}